Literature DB >> 17620097

Polymorphisms in NACHT-LRR (NLR) genes in atopic dermatitis.

Filippina Macaluso1, Michael Nothnagel, Qumar Parwez, Elisabeth Petrasch-Parwez, Falk Georges Bechara, Joerg Thomas Epplen, Sabine Hoffjan.   

Abstract

Atopic dermatitis (AD) is a chronic skin disease affecting up to 15% of children in industrialized countries. AD belongs to the group of atopic disorders characterized by excessive immune reactions to ubiquitous antigens. Complex interactions between genetic and environmental factors have been suggested for atopic disorders. Dysregulation of the innate immune system appears crucial for the pathogenesis of AD. The NACHT-LRRs (NLRs) represent a group of innate immune receptors with special relevance for inflammatory processes. In order to investigate the role of variation in NLR genes for AD, we genotyped 23 single nucleotide polymorphisms (SNPs) in seven selected NLR genes (CARD4, CARD15, CARD12, NALP1, NALP3, NALP12, MHC2TA) in 392 AD patients and 297 controls by restriction enzyme digestion or TaqMan assays. Single-SNP analysis demonstrated significant associations of the CARD15_R702W variation and the NALP12_In9 T-allele with AD (P = 0.008 and P = 0.03, resp.; insignificant after Bonferroni correction). In the CARD4 gene, a rare haplotype was more frequent in AD patients than in controls. Interactions between all pairs of SNPs in the seven genes were analysed by logistic regression. Significant interactions comprised SNPs in the CARD4 gene (CARD4_In1 and CARD4_Ex6, P = 6.56 x 10(-7); CARD4_Prom und CARD4_Ex6, P = 2.45 x 10(-4)) and promoter polymorphisms in the CARD12 and NALP1 genes (P = 4.31 x 10(-4)). In conclusion, variation in individual genes from the NLR family as well as interactions within this group of innate immune receptor genes could play a role in AD pathogenesis. Investigations in other populations and functional studies are warranted to clarify contributions of NLR variation for this frequent skin disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17620097     DOI: 10.1111/j.1600-0625.2007.00589.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  45 in total

1.  [Genetics of common chronic inflammatory skin diseases : An update on atopic dermatitis and psoriasis].

Authors:  E Rodríguez; K Eyerich; S Weidinger
Journal:  Hautarzt       Date:  2011-02       Impact factor: 0.751

Review 2.  Pattern recognition receptors in immune disorders affecting the skin.

Authors:  Heleen D de Koning; Anna Simon; Patrick L J M Zeeuwen; Joost Schalkwijk
Journal:  J Innate Immun       Date:  2012-03-06       Impact factor: 7.349

Review 3.  Unleashing the therapeutic potential of NOD-like receptors.

Authors:  Kaoru Geddes; João G Magalhães; Stephen E Girardin
Journal:  Nat Rev Drug Discov       Date:  2009-06       Impact factor: 84.694

Review 4.  Genetic and molecular basis of inflammasome-mediated disease.

Authors:  Hal M Hoffman; Susannah D Brydges
Journal:  J Biol Chem       Date:  2011-02-04       Impact factor: 5.157

Review 5.  Intracellular sensing of microbes and danger signals by the inflammasomes.

Authors:  Gabor L Horvath; Jacob E Schrum; Christine M De Nardo; Eicke Latz
Journal:  Immunol Rev       Date:  2011-09       Impact factor: 12.988

Review 6.  Autoinflammation: From monogenic syndromes to common skin diseases.

Authors:  Tien V Nguyen; Edward W Cowen; Kieron S Leslie
Journal:  J Am Acad Dermatol       Date:  2013-02-28       Impact factor: 11.527

Review 7.  Targeting Toll-like receptors: emerging therapeutics?

Authors:  Elizabeth J Hennessy; Andrew E Parker; Luke A J O'Neill
Journal:  Nat Rev Drug Discov       Date:  2010-04       Impact factor: 84.694

Review 8.  Molecular biology of atopic dermatitis.

Authors:  Zhanglei Mu; Yan Zhao; Xiaojing Liu; Christopher Chang; Jianzhong Zhang
Journal:  Clin Rev Allergy Immunol       Date:  2014-10       Impact factor: 8.667

Review 9.  The Genetics and Epigenetics of Atopic Dermatitis-Filaggrin and Other Polymorphisms.

Authors:  Yunsheng Liang; Christopher Chang; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2016-12       Impact factor: 8.667

10.  ATP binding by monarch-1/NLRP12 is critical for its inhibitory function.

Authors:  Zhengmao Ye; John D Lich; Chris B Moore; Joseph A Duncan; Kristi L Williams; Jenny P-Y Ting
Journal:  Mol Cell Biol       Date:  2007-12-26       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.